Matt Miksic
Stock Analyst at Barclays
(3.78)
# 2,033
Out of 4,629 analysts
807
Total ratings
53.7%
Success rate
3.4%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $96 → $89 | $49.31 | +80.49% | 50 | May 28, 2026 | |
| PODD Insulet | Maintained: Sell | $198 | $141.17 | +40.26% | 20 | May 28, 2026 | |
| DXCM DexCom | Rated: Sell | $67 → $64 | $84.75 | -24.48% | 22 | May 18, 2026 | |
| AVR Anteris Technologies Global | Maintained: Buy | $17 → $18 | $8.91 | +102.02% | 6 | May 15, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $255 | $259.24 | -1.64% | 93 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Rated: Buy | $12 → $13 | $4.24 | +206.60% | 7 | May 13, 2026 | |
| HUMA Humacyte | Rated: Buy | $1.5 | $0.7182 | +108.86% | 4 | May 13, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $202 → $204 | $176.86 | +15.35% | 23 | May 11, 2026 | |
| GMED Globus Medical | Maintained: Buy | $123 | $82.35 | +49.36% | 49 | May 11, 2026 | |
| SENS Senseonics Holdings | Maintained: Buy | $31 | $7.02 | +341.60% | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $55 | $22.38 | +145.76% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $76 | $76.22 | -0.29% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $15.31 | +24.10% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $24 | $9.31 | +157.79% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 72.56 → CHF 62.88 | CHF 57.34 | +9.67% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $27.55 | -2.00% | 41 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $469 → $394 | $339.03 | +16.21% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $16.78 | +19.19% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $78 | $71.77 | +8.68% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 → $94 | $96.55 | -2.64% | 40 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $110 | $89.72 | +22.60% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $712 → $651 | $378.81 | +71.85% | 19 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $144 → $143 | $107.81 | +32.64% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 → $120 | $87.16 | +37.68% | 68 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $19.60 | +32.65% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 | $74.23 | +38.76% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.86 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $722 → $418 | $173.66 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $0.06737 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $28 | $18.86 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $67 | $12.12 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $88.16 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $87 | $17.25 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $28.15 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $4.34 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $2.16 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $30.11 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $9.54 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $49.12 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $10.28 | n/a | 3 | Mar 14, 2013 |
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $96 → $89
Current: $49.31
Upside: +80.49%
Insulet
May 28, 2026
Maintained: Sell
Price Target: $198
Current: $141.17
Upside: +40.26%
DexCom
May 18, 2026
Rated: Sell
Price Target: $67 → $64
Current: $84.75
Upside: -24.48%
Anteris Technologies Global
May 15, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $8.91
Upside: +102.02%
Johnson & Johnson
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $259.24
Upside: -1.64%
Orchestra BioMed Holdings
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $4.24
Upside: +206.60%
Humacyte
May 13, 2026
Rated: Buy
Price Target: $1.5
Current: $0.7182
Upside: +108.86%
Becton, Dickinson and Company
May 11, 2026
Rated: Buy
Price Target: $202 → $204
Current: $176.86
Upside: +15.35%
Globus Medical
May 11, 2026
Maintained: Buy
Price Target: $123
Current: $82.35
Upside: +49.36%
Senseonics Holdings
May 11, 2026
Maintained: Buy
Price Target: $31
Current: $7.02
Upside: +341.60%
May 8, 2026
Maintained: Buy
Price Target: $56 → $55
Current: $22.38
Upside: +145.76%
May 7, 2026
Maintained: Hold
Price Target: $73 → $76
Current: $76.22
Upside: -0.29%
May 7, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $15.31
Upside: +24.10%
May 6, 2026
Maintained: Buy
Price Target: $27 → $24
Current: $9.31
Upside: +157.79%
May 6, 2026
Reiterated: Hold
Price Target: CHF 72.56 → CHF 62.88
Current: CHF 57.34
Upside: +9.67%
May 4, 2026
Maintained: Buy
Price Target: $25 → $27
Current: $27.55
Upside: -2.00%
May 1, 2026
Maintained: Buy
Price Target: $469 → $394
Current: $339.03
Upside: +16.21%
Apr 30, 2026
Maintained: Hold
Price Target: $20
Current: $16.78
Upside: +19.19%
Apr 30, 2026
Maintained: Hold
Price Target: $87 → $78
Current: $71.77
Upside: +8.68%
Apr 29, 2026
Maintained: Sell
Price Target: $100 → $94
Current: $96.55
Upside: -2.64%
Apr 24, 2026
Maintained: Buy
Price Target: $104 → $110
Current: $89.72
Upside: +22.60%
Apr 23, 2026
Rated: Buy
Price Target: $712 → $651
Current: $378.81
Upside: +71.85%
Apr 20, 2026
Rated: Buy
Price Target: $144 → $143
Current: $107.81
Upside: +32.64%
Apr 1, 2026
Maintained: Buy
Price Target: $118 → $120
Current: $87.16
Upside: +37.68%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $19.60
Upside: +32.65%
Mar 24, 2026
Reiterated: Buy
Price Target: $103
Current: $74.23
Upside: +38.76%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $1.86
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $722 → $418
Current: $173.66
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $16 → $13
Current: $0.06737
Upside: n/a
Mar 2, 2022
Maintained: Buy
Price Target: $31 → $28
Current: $18.86
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $74 → $67
Current: $12.12
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $100
Current: $88.16
Upside: n/a
Nov 3, 2021
Maintained: Buy
Price Target: $79 → $87
Current: $17.25
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $28.15
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $4.34
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $2.16
Upside: n/a
Nov 3, 2014
Maintained: Hold
Price Target: $37
Current: $30.11
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $9.54
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $49.12
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $10.28
Upside: n/a